#53 Advantages and limitations of ‘delayed prescriptions’ of antibiotics for upper respiratory tract infections (URTI)
Reading Tools for Practice Article can earn you MainPro+ Credits
Join NowAlready a CFPCLearn Member? Log in
- Cochrane systematic review:1
- Nine randomized controlled trials (RCTs) compared delayed to immediate antibiotic:
- Filled antibiotic prescriptions: 32% in delayed group versus 93% in immediate.
- Outcomes of delayed versus immediate (statistically significant differences reported):
- Bronchitis or common cold: No difference.
- Pharyngitis: Two studies found fever severity at day three worse with delayed but other outcomes not different.
- Otitis media: One study found pain severity and malaise at day three worse with delayed but other outcomes not different.
- Delayed slightly reduced patient satisfaction (87% versus 92%).
- In one study, return-to-care rate lower with delayed.
- Adverse events: Two studies found reduced diarrhea in delayed group; other studies showed no differences.
- Nine randomized controlled trials (RCTs) compared delayed to immediate antibiotic:
- New RCTs:
- In patients previously prescribed antibiotics for cough, delayed prescriptions reduced return-to-care rates.2
- No difference among four different methods of delayed prescriptions in symptom severity, duration, return-to-care rates or patient satisfaction.3
- Antibiotic use: 26% in no antibiotic group and 37% in delayed.
- Other systematic review had similar findings.4,5
- Concerns with antibiotics included:
- May promote resistant bacteria in the user and in the population.6,7
- Frequent side effects (e.g. rash, diarrhea).8
- Three RCTs compared delayed antibiotic to no antibiotic1
- 14% in no-antibiotic group filled an antibiotic prescription versus 32% in delayed group.
- Delayed prescriptions are not appropriate when patients:
- Present with worse symptoms9 (for example, in children with otitis media, those with fever or vomiting did worse with delayed antibiotics).10
- Have important comorbidities (e.g. heart failure).9
- Have barriers to accessing follow up care.